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The simian parainfluenza virus 5 (SV5) V/P gene encodes two proteins: V and the phosphoprotein P. The V and P proteins
are amino coterminal for 164 residues, but they have unique carboxyl termini. The unique carboxyl terminus of V contains
seven cysteine residues, resembles a zinc finger, and binds two atoms of zinc. In a glutathione-S-transferase (GST)-fusion
protein selection of cell lysate assay, the GST-V protein was found to interact with the 127-kDa subunit (DDB1) of the
damage-specific DNA binding protein (DDB) [also known as UV-damaged DNA binding protein (UV-DDB), xeroderma
pigmentosum group E binding factor (XPE-BF), and the hepatitis B virus X-associated protein 1 (XAP-1)]. A reciprocal
GST-DDB1 fusion protein selection assay of SV5-infected cell lysates showed that DDB1 and V interact, and it was found that
V and DDB1 could be coimmunoprecipitated from SV5-infected cells or from cells expressing V and DDB1 using the vaccinia
virus T7 expression system. The interaction of V and DDB1 involves the carboxyl-terminal domain of V in that either deletion
of the V carboxyl-terminal domain or substitution of the cysteine residues (C189, C193, C205, C207, C210, C214, and C217)
in the zinc-binding domain with alanine was able to disrupt binding to DDB1. The V proteins of the mumps virus, human
parainfluenza virus 2 (hPIV2), and measles virus have also been found to interact with DDB1 in GST-fusion protein selection
assays using in vitro transcribed and translated DDB1. © 1998 Academic Press
INTRODUCTION
Simian parainfluenza virus 5 (SV5) is an enveloped
virus with a nonsegmented, single-stranded, negative-
sense RNA genome of 15,246 nucleotides. SV5 is clas-
sified as a member of the genus Rubulavirus in the virus
family Paramyxoviridae, a family that includes Sendai
virus, human parainfluenza virus types 1–4, measles vi-
rus, mumps virus, and Newcastle disease virus (re-
viewed in Lamb and Kolakofsky, 1996). The SV5 genome
contains seven genes that encode for eight proteins; the
V/P gene encodes for two proteins: the V protein (V) and
the phosphoprotein (P) (Paterson et al., 1984). The V
mRNA is a faithful copy of the V/P gene, whereas the P
mRNA contains two nontemplated G residues added at a
specific site (Thomas et al., 1988), which changes the
reading frame of the remainder of the P mRNA relative to
the V mRNA. As a result, the SV5 V and P proteins share
164 amino-terminal amino acids but have unique carbox-
yl-terminal domains (Fig. 1) (Thomas et al., 1988). The
available data suggest the two G residues are added
cotranscriptionally by the viral polymerase as it stutters
at a sequence 39-AAAAUUCU-59 found upstream of the
insertion site (Thomas et al., 1988; Vidal et al., 1990). This
sequence is similar to the viral polyadenylation signal at
which the viral polymerase stutters and reiteratively cop-
ies a short stretch of Us to generate the long poly(A)1 tail
(Thomas et al., 1988; Vidal et al., 1990). Pseudotemplated
transcription of nucleotides occurs with the majority of
paramyxoviruses to yield P- and V-specific mRNAs, al-
though in some cases the P mRNA is encoded by the
genome RNA and the V mRNA contains the additional
nucleotide or nucleotides (reviewed in Jacques and Ko-
lakofsky, 1991).
The sequences of the P proteins of members of the
Paramyxoviridae family are not highly conserved, but
the sequences of the unique carboxyl terminus of the
V proteins are highly conserved: they contain seven
cysteine residues arranged such that the carboxyl
terminus resembles a zinc finger (Fig. 1) (Thomas et
al., 1988). It has been shown that the measles virus,
SV5, and Newcastle disease virus V proteins bind
atomic zinc (Liston and Briedis, 1994; Paterson et al.,
1995; Steward et al., 1995).
The P protein has been proposed to be involved in
both genome replication and transcription. The P protein
interacts with the polymerase protein (L) to form the
polymerase complex for replication and transcription of
the nucleoprotein (NP)-encapsidated genome (Curran et
al., 1992; Horikami et al., 1992). The P protein is also
involved in the RNA encapsidation process: during syn-
thesis of the antigenomic and genomic RNA, a complex
between P and NP forms to keep NP soluble before NP
binds to the nascent RNA chain (Curran et al., 1995;
Horikami et al., 1992).
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In contrast to the known functions of P in viral repli-
cation and transcription, the role of the V protein in the
viral life cycle is poorly understood. The SV5 V protein
has been found associated with the nucleocapsid in
virions (Paterson et al., 1995), and the V (and P) protein of
SV5 binds RNA through a basic region (residues 74–81)
(Lin et al., 1997). The V and P proteins of measles virus,
Sendai virus, and SV5 have been found in the cytoplasm
of infected cells (Curran et al., 1991b; Paterson et al.,
1995; Wardrop and Briedis, 1991). However, the SV5 and
human parainfluenza virus 2 (hPIV2) V proteins have also
been found to have a diffuse nuclear localization (Pater-
son et al., 1995; Precious et al., 1995; Watanabe et al.,
1996). The function of the V protein in the nucleus of
infected cells is not known, especially in view of the fact
that the replication cycle of paramyxoviruses is thought
to take place in the cytoplasm (reviewed in Lamb and
Kolakofsky, 1996).
The possible role of the V protein in viral RNA replica-
tion has been investigated in an in vitro assay that
determined the amount of replication of a Sendai virus
defective-interfering RNA when NP, L, and P were ex-
pressed from cDNAs (Curran et al., 1991a). Replication
was found to be inhibited 60–70% by the coexpression of
the V protein (Curran et al., 1991a). The amino-terminal
domain of P and V is necessary for interaction with
soluble NP (Curran et al., 1995; Randall and Bermingham,
1996), and thus it has been suggested that V inhibits the
replication process by interacting with NP and thereby
preventing NP from interacting with P and assembling
into the nucleocapsid structure during replication (Cur-
ran et al., 1995; Horikami et al., 1996).
Reverse genetics experiments using infectious cDNA
clones representing the viral genome have permitted
further examination of the role of the V protein in the viral
life cycle. Recombinant Sendai virus and measles virus
that are unable to synthesize the V protein [V(2) virus]
have been recovered, indicating the V protein is not
essential for replication in tissue culture (Delenda et al.,
1997; Kato et al., 1997a; Schneider et al., 1997). However,
the Sendai virus V protein was found to be essential for
pathogenicity in the natural host, the mouse (Kato et al.,
1997a, 1997b). Mice infected with either the V(2) virus or
a virus deficient in the V carboxyl-terminal domain (VDC)
showed greatly reduced morbidity rates compared with
mice infected with wild-type Sendai virus (Kato et al.,
1997a, 1997b), suggesting that the carboxyl-terminal do-
main of the Sendai virus V protein is important for patho-
genicity (Kato et al., 1997a,b).
The data obtained with the V(2) and VDC recombinant
Sendai viruses in tissue culture cells and in the mouse
suggest that the V protein may affect host cells by inter-
acting with host cell proteins. Furthermore, because the
paramyxovirus V proteins have highly conserved zinc-
binding domains and because such domains have been
shown previously to participate in protein–protein inter-
actions (reviewed in Berg, 1989; O’Halloran, 1993), the
carboxyl-terminal domain of the V proteins may interact
with host cell proteins. Indeed, when the SV5 V or P
proteins were expressed in inducible cell lines, the V
protein was found to coimmunoprecipitate a ;150-kDa
host cell protein, whereas the P protein did not, indicat-
ing that the interaction requires the unique carboxyl-
terminal domain of the V protein (Precious et al., 1995).
We show here that the SV5 V protein interacts with the
127-kDa subunit of the damage-specific DNA binding pro-
tein (DDB1) [also known as the UV-damaged DNA binding
protein (UV-DDB), xeroderma pigmentosum group E bind-
ing factor (XPE-BF), or the hepatitis B virus X-associated
protein 1 (XAP-1)]. The interaction of V and DDB1 involves
the carboxyl-terminal domain of V because either deletion
of the V carboxyl-terminal domain or substitution of any of
the conserved cysteine residues of the zinc-binding domain
largely disrupts the interaction of these two proteins. In
glutathione-S-transferase (GST)-fusion protein selection as-
says, the V proteins of mumps virus, hPIV2, and measles
virus have also been found to interact with in vitro tran-
scribed and translated DDB1.
FIG. 1. Schematic of the SV5 V and P proteins. (Cross-hatched area of the V protein) Unique carboxyl terminus of V with the cysteine residues,
presumably involved in zinc binding (p). (Shaded region) Unique carboxyl terminus of P.
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RESULTS
The SV5 V protein interacts with a ;115-kDa host cell
protein
To determine whether the SV5 V protein interacts with
host cell proteins, the ability of immobilized GST-fusion
proteins to bind to soluble proteins from cell lysates was
investigated. Subconfluent cultures of Madin–Darby ca-
nine kidney (MDCK), Madin–Darby bovine kidney (MDBK),
or CV-1 cells were labeled with [35S]Promix, and cell
lysates were incubated with the GST-fusion proteins im-
mobilized on glutathione–Sepharose 4B beads. The
beads were washed extensively, and the host cell pro-
teins that bound to the GST-fusion proteins were ana-
lyzed by SDS–PAGE, followed by autoradiography. As
shown in Figure 2A, a GST-fusion protein containing SV5
V protein (GST-V) associated with a prominent MDCK
cell-derived ;115-kDa polypeptide species. In contrast,
the glutathione–Sepharose 4B either alone (beads) or
bound with GST, a GST-fusion protein with the heptad
repeat B region of the SV5 F protein (GST-H2), or a
GST-fusion protein containing SV5 P (GST-P) did not
associate with the ;115-kDa polypeptide. Other poly-
peptide species were observed, but they were consis-
tently observed among immobilized GST and GST-fusion
proteins, and thus they were considered to be proteins
trapped by GST/GST-fusion proteins in general. The
;115-kDa host cell protein also did not interact with
fusion proteins of the small GTP binding proteins: GST-
Rho and GST-Rac (data not shown). These data suggest
that the interaction between V and the ;115-kDa host
cell protein is specific, and because the ;115-kDa pro-
tein did not interact with the P protein, it is suggested
that the interaction required the unique carboxyl-terminal
domain of the V protein. Parallel data were obtained with
lysates of MDBK (data not shown) and CV-1 cells (see
below), suggesting the ;115-kDa protein is conserved
among mammalian species.
To determine further whether the interaction between
V protein and the ;115-kDa host cell protein occurs in
virus-infected cells, we investigated whether the ;115-
kDa host cell protein could be coimmunoprecipitated
with V protein from SV5-infected cells. As shown in
Figure 2B, when lysates of SV5-infected cells were im-
munoprecipitated with monoclonal antibody (mAb) P-k,
which is specific for the shared amino terminus of V and
P, small amounts of the ;115-kDa host cell protein were
coimmunoprecipitated. However, because mAb P-k pre-
cipitates P and V, P interacts with L (Curran et al., 1992;
Horikami et al., 1992), and P and V interact with NP
FIG. 2. The SV5 V protein interacts with a ;115-kDa host cell protein. (A) GST-fusion protein selection of cell lysate assay. GST-fusion proteins
immobilized on glutathione–Sepharose 4B were incubated with a lysate of [35S]-labeled MDCK cells, and the beads were washed as described in
Materials and Methods. The cellular proteins bound to the GST-fusion proteins were analyzed by SDS–PAGE on a 10% gel and detected by
autoradiography. GST-fusion protein selection assays were performed with beads, glutathione–Sepharose 4B beads alone; GST, glutathione
S-transferase protein; GST-H2, GST-fusion protein constructed with SV5 F protein heptad repeat B; GST-P, GST-P fusion protein; and GST-V, GST-V
fusion protein. (B) Coimmunoprecipitation of the ;115-kDa host cell protein from CV-1 cells infected with SV5 or with recombinant SV40 expressing
the SV5 V protein (SV40-V), expressing the SV5 hemagglutinin–neuraminidase (HN), or mock infected. Cells were metabolically labeled with
[35S]Promix, and cell lysates were immunoprecipitated with mAb P-k, which is specific for the shared amino terminus of V and P. In SV5-infected cells,
NP and L are also coimmunoprecipitated with V and P. The results of two separate experiments are shown.
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(Curran et al., 1995; Randall and Bermingham, 1996), the
specific association of V with the ;115-kDa protein could
not be shown. Thus, CV-1 cells were infected with a
simian virus 40 (SV40)-recombinant virus that expresses
the V protein (SV40-V). Cell lysates were immunoprecipi-
tated with mAb P-k, and the ;115-kDa protein was found
to coimmunoprecipitate with V protein. The ;115-kDa
host cell protein was not immunoprecipitated with mAb
P-k from lysates of mock-infected cells or from cells
infected with a SV40 recombinant virus expressing the
SV5 hemagglutinin–neuraminidase.
Identification of the ;115-kDa protein by peptide and
protein sequence analysis
To obtain amino acid sequence information on the
;115-kDa protein, GST-V fusion protein selection was
used to isolate the ;115-kDa protein from lysates of
eight 10-cm-diameter plates of uninfected MDCK cells.
The ;115-kDa protein was analyzed on SDS-PAGE, and
the gel was reverse stained with zinc sulfate and imida-
zole as previously described (Ortiz et al., 1992). The
;115-kDa host cell protein was excised from the gel and
digested in the gel slice with LysC protease. The masses
of the peptides were analyzed by mass spectrometry,
and the sequence of one of the peptides was determined
by mass spectrometry to be VVEELTRIH. The actual
peptide masses were compared with the predicted
masses of peptides after a virtual digestion with LysC of
proteins found in the Swiss Prot database, and the pep-
tide sequence was also compared with the sequences
found in the Swiss Prot database. The peptide sequence
matched a carboxyl-terminal peptide of the 127-kDa sub-
unit (DDB1) of DDB, and the sequence combined with the
peptide masses indicated with a high degree of certainty
that the ;115-kDa protein was DDB1. The DDB protein
was initially characterized as a nuclear protein factor that
bound to DNA damaged by UV light, cisplatin, and de-
naturation (Chu and Chang, 1988). DDB was purified and
shown to consist of a heterodimer of 127-kDa (DDB1)
and 48-kDa (DDB2) subunits that are weakly associated
(Keeney et al., 1993). DDB1 is a highly conserved protein
with an identical sequence between the simian and
human proteins except for one conservative amino acid
change (Dualan et al., 1995; Lee et al., 1995; Takao et al.,
1993).
The ;115-kDa protein is detected by immunoblotting
with antibodies to DDB1
To provide alternative evidence that the ;115-kDa
protein that interacts with GST-V is DDB1, it was selected
on immobilized GST-V from [35S]-labeled CV-1 cell ly-
sates, and selected proteins were analyzed by SDS–
PAGE and transferred to Immobilon-P (Millipore Corp.,
Bedford, Massachusetts) membranes. The proteins on
membranes were detected by autoradiography, and the
same membranes were probed by immunoblotting using
antisera specific for the simian or human DDB1 proteins.
Autoradiograms of [35S]-labeled ;115-kDa host cell pro-
tein that was selected by immobilized GST-V, but not GST
or GST-P, are shown in Figures 3A and 3C. Immunoblot-
ting of the membrane from Figure 3A with polyclonal sera
(DDB) specific for a carboxyl-terminal peptide fragment
of purified simian DDB1 indicated that this sera recog-
nized the ;115-kDa protein selected by GST-V (Fig. 3B).
Immunoblotting of the membrane from Figure 3C was
performed using a polyclonal sera (XAP-1 peptide 1)
raised to an amino-terminal peptide of human DDB1 (Fig.
3D). The membrane was then stripped of antibodies and
reprobed using a polyclonal sera (XAP-1 peptide 2) spe-
cific to a carboxyl-terminal peptide of human DDB1 (Fig.
FIG. 3. The ;115-kDa host cell protein selected with the GST-V protein is the 127-kDa subunit of DDB. The GST-fusion protein selection assays
were performed with CV-1 cell lysates and washed as described in Materials and Methods. The proteins were separated by SDS–PAGE and
transferred to Immobilon-P membranes. The proteins on the membranes were detected by autoradiography or by immunoblotting. (A) Autoradiogram
of GST-fusion protein selection. (B) Immunoblotting of membrane from A with a polyclonal sera (DDB) specific for a carboxyl-terminal peptide of simian
DDB1. (C) Autoradiogram of GST-fusion protein selection. (D and E) Immunoblotting of membrane from C with polyclonal sera (XAP-1 peptide 1)
specific for an amino-terminal peptide from human DDB1 (D) or with polyclonal sera (XAP-1 peptide 2) specific for a carboxyl-terminal peptide of
human DDB1 (E). GST-fusion protein selections were performed with the following: GST, GST protein; GST-P, GST-P fusion protein; and GST-V, GST-V
fusion protein.
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3E). Both the amino- and carboxyl-terminal antibodies
detected the ;115-kDa protein selected by immobilized
GST-V, thus confirming that the ;115-kDa protein is the
127-kDa subunit of DDB.
GST-DDB1 interacts with V protein from SV5-infected
cells
To extend the observation that DDB1 interacts with
SV5 V, a cDNA to the human 127-kDa subunit of DDB was
isolated by reverse transcription (RT)-polymerase chain
reaction (PCR) using sequence-specific primers, and the
cDNA was subcloned into pGEX-5X-3 such that a GST-
DDB1 fusion protein could be expressed and used to
select proteins from lysates of mock-infected or SV5-
infected cells. Selected proteins were separated by
SDS–PAGE and transferred to an Immobilon-P mem-
brane. Immunoblotting was performed using mAb P-k,
which is specific for the shared amino terminus of V and
P proteins. As shown in Figure 4, immobilized GST-DDB1
selected the V protein (but not the P protein) from SV5-
infected cells. Thus, these data indicated that the inter-
action between V and DDB1 proteins can be detected in
the reverse GST-fusion protein selection and confirm that
DDB1 does not interact strongly with the P protein, which
shares 164 amino-terminal residues with the V protein.
The zinc-binding domain of V is required for
interaction with DDB1
The carboxyl-terminal domain of the SV5 V protein
contains seven cysteine residues arranged in a motif
that resembles a zinc finger (Thomas et al., 1988), and
the SV5 V protein has been shown to bind two atoms of
zinc (Paterson et al., 1995). Zinc-binding domains have
been previously implicated in protein–protein interac-
tions (reviewed in Berg, 1989; O’Halloran, 1993). Thus, to
show that the V carboxyl-terminal domain is an important
component in the interaction of V protein with DDB1, a
GST-V fusion protein lacking the carboxyl-terminal do-
main (D168–222) was tested in a GST-fusion protein
selection assay, using CV-1 cell lysates. As shown in
Figure 5, immobilized GST-VD168–222 did not retain
DDB1. As discussed above, GST and the GST-fusion
proteins selected other protein species that we consider
to be general nonspecific trapping of protein. Substitu-
tion of cysteine residues in zinc finger proteins often
perturbs the zinc finger structure (reviewed in Berg,
1989). To test the importance of the cysteine residues in
the carboxyl-terminal domain of the V protein for inter-
action with DDB1, each cysteine residue was substituted
FIG. 4. GST-DDB1 interacts with the V protein but not the P protein from
SV5-infected cells. GST-fusion protein selection assays were performed
with either mock-infected (Mock) or SV5-infected (SV5) cell lysates, and the
beads were washed as described in Materials and Methods. The polypep-
tides were separated by SDS–PAGE on a 15% gel, transferred to an
Immobilon-P membrane, and detected by immunoblotting with mAb P-k.
GST-fusion protein selections were performed with the following: GST,
GST protein; or GST-DDB1, GST fusion protein with the 127-kDa subunit of
DDB. SV5, direct load of SV5-infected cell lysate.
FIG. 5. The interaction of SV5 V protein and DDB1 requires the
zinc-binding domain. GST-fusion protein selection assays were per-
formed using CV-1 lysates as described in Materials and Methods.
GST-fusion protein selection assays were performed with the following:
beads, glutathione–Sepharose 4B; GST, GST protein; GST-P, GST-P
fusion protein; GST-V, GST-V fusion protein; D168–222, GST-V fusion
protein with residues 168–222 (the unique carboxyl-terminal domain of
the V protein) deleted; and C189A, C193A, C205A, C207A, C210A,
C214A, and C217A, GST-V fusion proteins with the cysteine residues in
the zinc-binding domain substituted for alanine.
193DDB INTERACTS WITH SV5 V PROTEIN
for alanine (C189A, C193A, C205A, C207A, C210A, C214A,
or C217A). The GST-V cysteine mutants were used in cell
lysate selection assays. As shown in Figure 5, each of
the cysteine substitutions abolished the interaction be-
tween GST-V and DDB1. These data suggest that each of
the cysteine residues is important for maintaining the
structure of the zinc-binding domain and that alterations
in the structure of this domain disrupts binding to DDB1.
Because it is difficult to determine whether the fusion
protein component of GST-fusion protein is folded in its
native form, it was considered important to verify the V
protein–DDB1 protein interaction using naturally ex-
pressed proteins. The V protein, VD168–222, P protein,
and DDB1 were expressed from cDNAs using the recom-
binant vaccinia T7 RNA polymerase expression system,
and the proteins were reciprocally immunoprecipitated.
As shown in Figure 6A, DDB1 could be coprecipitated
with V using the V/P-specific mAb P-k. However, DDB1
was not coprecipitated with the V/P-specific sera when
DDB1 and either P or VD168–222 were coexpressed. In a
reciprocal experiment, the same cell lysates were immu-
noprecipitated with the rabbit sera (XAP-1 peptide 2)
specific for a carboxyl-terminal peptide of DDB1. As
shown in Figure 6B, endogenous DDB1 expression was
not detected using the DDB1-specific sera (lane pGEM),
but the overexpressed exogenous DDB1 could be de-
tected (lane DDB1). When V protein was coexpressed
with DDB1, the DDB1 sera coprecipitated V protein.
When the P protein or VD168–222 was coexpressed with
DDB1, neither P nor VD168–222 was coprecipitated with
the DDB1 sera. These data support the GST-fusion pro-
tein selection of host cell protein experiments and con-
firm that the carboxyl-terminal domain of the V protein is
important for the interaction with DDB1.
Interaction of the V protein of other paramyxoviruses
with DDB1
The sequence of the carboxyl-terminal cysteine-rich
domain of SV5 V protein is highly conserved among
paramyxoviruses, and this domain is important for the
association of SV5 V protein with DDB1. Thus, the pos-
sible interaction of DDB1 with the V proteins of other
paramyxoviruses was studied. GST-V fusion proteins,
with V protein derived from mumps virus, hPIV2, Sendai
virus, and measles virus, were used in selection exper-
iments using lysates from MDCK and CV-1 cells. How-
ever, under the conditions used, the V proteins from
viruses other than SV5 were not found to associate with
DDB1 (data not shown). Because the GST-fusion protein
selection assays were performed using 0.65 M NaCl-
and 0.1% SDS-containing buffer, we turned to less strin-
gent salt and detergent washing conditions. In addition,
because it was difficult to label metabolically DDB1 to
high specific activity, [35S]methionine-labeled DDB1
translated in vitro was used in GST-fusion protein selec-
tion experiments. As shown in Figure 7, glutathione–
Sepharose 4B alone (lane beads) did not interact with
the in vitro translated DDB1. Immobilized GST, a GST-
fusion protein of the SV5 F protein heptad repeat B
(GST-H2), and a GST-fusion protein of influenza C virus
matrix protein (GST-CM1) served as controls for nonspe-
cific trapping of full-length DDB1. GST-V (SV5) was found
to select DDB1 as found for in vivo synthesized V (Fig. 2).
Smaller products than DDB1 that are trapped by the
GST-fusion proteins are considered likely to be trunca-
tion or internal initiation products of DDB1. The mumps
virus, hPIV2, and measles virus GST-V fusion proteins
also selected the in vitro translated DDB1, whereas the
Sendai virus V protein did not select DDB1 (Fig. 7). Thus,
these data suggest that the V proteins of other members
of the paramyxovirus family can also interact with DDB1.
Antibodies specific for SV5 V protein (Paterson et al.,
FIG. 6. Coimmunoprecipitation of the V protein and DDB1 requires
the zinc-binding domain. V, P, mutant V, and DDB proteins were ex-
pressed using the recombinant vaccinia virus T7 RNA polymerase
transient expression system (Fuerst et al., 1986). Then, 60-mm-diameter
dishes were transfected with 5.0 mg of pGEM3-DDB1 and 2.5 mg of the
pGEM2-V, P, or VD168–222 plasmids. Where appropriate, pGEM3 DNA
was added such that 7.5 mg of DNA was used in each transfection.
Cells were labeled with [35S]Promix, and an aliquot of each lysate was
immunoprecipitated with mAb P-k specific for the shared amino-termi-
nal domain of P and V (A) or with an antiserum (XAP-1 peptide 2)
specific for the carboxyl-terminal domain of DDB1 (B). The immunopre-
cipitated proteins were separated by SDS–PAGE on a 15% gel, and the
polypeptides were analyzed by autoradiography. pGEM, lysate from
cells transfected with pGEM3; DDB1, lysate from cell transfected with
pGEM3-DDB1; DDB1V, lysate from cells transfected with pGEM3-
DDB1 and pGEM2-P/V203–1; DDB1P, lysate from cells transfected
with pGEM3-DDB1 and pGEM2-P/V123; and DDB1VD168–222, lysate
from cells transfected with pGEM3-DDB1 and pGEM2-VD168–222.
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1995) block detection of the interaction of V with DDB1
(data not shown), presumably due to competition for
interaction with the zinc-binding domain, and for most
paramyxovirus V proteins, antisera are not available ex-
cept for those made against the zinc finger. However,
measles virus V protein contains a carboxyl-terminal
extension beyond the zinc finger, and a specific serum
was generated to this domain (Liston and Briedis, 1994).
Thus, to show further that the measles virus V protein
interacts with DDB1, the measles V protein and DDB1
were coexpressed using the recombinant vaccinia virus
T7 RNA polymerase expression system. Cell lysates
were immunoprecipitated with measles V-specific sera,
and immune complexes were washed in buffer contain-
ing 0.15 M NaCl, conditions less stringent than those
used for the SV5 V and DDB1 coimmunoprecipitations
(0.65 M NaCl). As shown in Figure 8, although some
nonspecific polypeptide species were observed in all
lanes, including the control lanes, in cells expressing the
measles virus V protein, V was immunoprecipitated, and
in cells coexpressing V protein and DDB1, DDB1 was
coimmunoprecipitated with V protein (Fig. 8). Thus, these
data further support the notion that measles V protein
can interact with DDB1.
DISCUSSION
Although the Sendai virus and measles virus V pro-
teins were determined to be nonessential for viral repli-
cation in tissue culture (Delenda et al., 1997; Kato et al.,
1997a, 1997b; Schneider et al., 1997), the Sendai virus V
protein is required for pathogenicity in the natural host
(Kato et al., 1997a, 1997b). These results have suggested
that the V protein may interact with host cell factors to
mediate pathogenicity. Furthermore, the V proteins of the
Paramyxoviridae family have highly conserved carboxyl-
terminal domains with seven cysteine residues that have
been shown to bind zinc (Liston and Briedis, 1994; Pater-
son et al., 1995; Steward et al., 1995), and zinc-binding
domains have been previously reported to be involved in
protein–protein interactions (reviewed in Berg, 1989). It is
generally thought that interaction of the cysteine resi-
FIG. 7. The V proteins of SV5 and other paramyxoviruses interact
with in vitro transcribed and translated DDB1 in GST-fusion protein selec-
tion assays. DDB1 mRNA was transcribed from pGEM3-DDB1 using T7
RNA polymerase and translated in lysates of rabbit reticulocytes in the
presence of [35S]methionine as described in Materials and Methods. The
GST-fusion proteins and the in vitro translated DDB1 were incubated and
washed in Nonidet P-40 buffer as described in Materials and Methods.
The bound proteins were analyzed by SDS–PAGE on 10% gels, followed by
autoradiography. GST-fusion protein selection assays were performed
with the following: beads, glutathione–Sepharose 4B; GST, GST protein;
GST-H2, GST fusion protein with the heptad repeat B region of the SV5 F
protein; GST-CM1, GST fusion protein with the matrix (M1) protein of
influenza C; GST-V(SV5), SV5 GST-V fusion protein; GST-V(mumps), mumps
GST-V fusion protein; GST-V (hPIV2), hPIV2 GST-V fusion protein; GST-V
(Sendai), Sendai virus GST-V fusion protein; and GST-V (measles), measles
virus GST-V fusion protein.
FIG. 8. The measles virus V protein coimmunoprecipitates DDB1.
Measles V and DDB1 were expressed using the recombinant vaccinia
T7 RNA polymerase transient expression system as described in the
legend to Figure 6. The lysates were immunoprecipitated with poly-
clonal sera specific to a carboxyl-terminal peptide of V located carboxyl
terminal to the V protein cysteine residues (Wardrop and Briedis, 1991).
pGEM, lysate from cells transfected with pGEM3; measles V, lysate
from cells transfected with pGEM2-measles V; DDB1, lysates from cells
transfected with pGEM3-DDB1; and measles V1DDB1, lysates from
cells transfected with pGEM2-measles V and pGEM3-DDB1.
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dues with zinc ions is required to maintain the confor-
mation of proteins with zinc-binding domains and that
substitution of any one of the cysteine residues with
alanine is sufficient to perturb the structure of these
domains (reviewed in Berg, 1989).
We have shown that the SV5 V protein, in GST-fusion
protein selection assays and in coimmunoprecipitation
assays, interacts with the 127-kDa subunit of DDB. The
identity of DDB1 was shown by protein sequencing and
verified by immunoblotting with antibodies specific for
DDB1. The interaction between V and DDB1 requires an
intact zinc-binding domain of the V protein in that either
deletion of the carboxyl-terminal domain or substitution
of any one of the cysteine residues in the carboxyl-
terminal domain with alanine disrupted the interaction
with DDB1. The available evidence also indicates that the
V proteins of mumps virus, hPIV2, and measles virus can
interact with DDB1. However, the Sendai virus V protein
did not interact with DDB1. It is possible that this is
because unlike the sequences of the V proteins of SV5,
measles virus, mumps virus and hPIV-2, the Sendai virus
V protein sequence contains several charged residues
upstream of the conserved cysteine residues (see com-
parison of sequences in Thomas et al., 1988).
Xeroderma pigmentosum (XP) is a human autosomal
recessive disease characterized by a high incidence of
cancer, especially skin cancer, and by neurological dis-
orders, due to defects in the nucleotide excision repair of
damaged DNA (reviewed in Sancar, 1996). XP appears to
be caused by mutations in different genes in patients
with the disease, and seven XP complementation groups
as well as one variant type (XP-A to XP-G and XP-V) have
been identified (reviewed in Sancar, 1996). The mutations
in these complementation groups have been character-
ized, and the wild-type proteins appear to participate in
different steps of the nucleotide excision repair process
(reviewed in Sancar, 1996). Some patients associated
with the XP complementation group E (XP-E) were found
to have a DDB complex that lacks its normal activity of
binding to DNA, which has been damaged by UV light,
cisplatin, and denaturation (Chu and Chang, 1988). When
DDB was purified, it was found to consist of a weakly
associated heterodimer of a 127-kDa subunit (DDB1) and
a 48-kDa subunit (DDB2) (Keeney et al., 1993). DDB1 is
highly conserved as the simian and human sequences
share .98% DNA sequence homology and identical pro-
tein sequences except for one conservative amino acid
change (Dualan et al., 1995; Lee et al., 1995; Takao et al.,
1993). Furthermore, significant homology with the repE
protein in Dictyostelium discoideum (slime mold) and a
protein in Oryza sativa (rice) has been found (Alexander
et al., 1996; Takao et al., 1993).
The function of DDB in nucleotide excision repair is
not well understood. Injection of DDB into XP-E cells
lacking DDB activity was found to correct the repair
defect, indicating that DDB may play an essential role in
recognition of damaged DNA for the nucleotide excision
repair system (Keeney et al., 1994). However, other re-
ports have indicated that DDB may not be essential to
the nucleotide excision repair process because DDB
was found not to be obligatory but only to stimulate
repair activity in an in vitro reconstituted nucleotide ex-
cision repair assay (Aboussekhra et al., 1995). Further-
more, XP-E repair defects have also been complemented
with the human replication/repair protein A (RPA), al-
though mutations in RPA were not found in the XP-E cells
(Kazantsev et al., 1996).
Recent evidence has also suggested that DDB1 is
involved in transcription. A homo-oligomer of DDB1 has
been found to bind to the hepatic-specific cis-acting
promoter sequence of the human apolipoprotein B-100
gene (Krishnamoorthy et al., 1997). In addition, the DDB
complex has been found to interact with the transcription
factor E2F1, and DDB was found to overcome the inhibi-
tion of E2F1 transactivation caused by the retinoblas-
toma gene product (Rb 105) (Hayes et al., 1998). It has
been suggested that on DNA damage, DDB binds to the
damaged areas and is no longer able to interact with
E2F1, and thus E2F1 remains bound by Rb 105 (Hayes et
al., 1998). Because E2F1 appears to be important for
entry into S phase of the cell cycle, this lack of interaction
with DDB may be important in downregulating the repli-
cation genes and slowing down cell growth during the
repair process (Hayes et al., 1998). Fibroblast cell lines
from XPE patients that lack DDB activity have been found
to grow poorly and replicate slowly compared with wild-
type fibroblasts (unpublished observations), a finding
consistent with the possibility that DDB plays a role in
cell cycle progression.
DDB1 has previously been shown to interact with
another viral protein, the hepatitis B virus (HBV) X protein,
but the significance of the interaction is not known (Lee
et al., 1995). The function of the X protein is not well
understood. The X protein does not appear to be re-
quired for replication in tissue culture, but it does appear
to be essential for viral replication in vivo because a
recombinant woodchuck hepatitis virus that was unable
to synthesize the X protein was not able to replicate
(reviewed in Ganem, 1996). The X protein appears to
have an upregulatory effect on various viral and cellular
promoters (reviewed in Ganem, 1996), and it has been
suggested that the X protein is important for the devel-
opment of hepatocellular carcinoma in patients infected
with HBV (reviewed in Butel et al., 1996). The interaction
of the X protein with DDB1 has been reported to inhibit
the nucleotide excision repair process, and it has been
suggested that HBV may cause hepatocellular carci-
noma by interfering with the repair of damaged DNA,
leading to the accumulation of mutations and the de-
velopment of cancer (Becker et al., 1998). Cells stably
transfected with the X gene showed increased transac-
tivation of some reporter genes with cellular promoters,
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but they also grew more slowly and showed growth
phase arrest (Lee et al., 1998). These results further
suggest that the interaction between X protein and DDB1
could also inhibit the interaction between DDB1 and
E2F1, decrease E2F1 transactivation, and thus slow cell
cycle progression.
The role of the interaction between the SV5 V protein
and DDB1 in the viral life cycle remains to be deter-
mined. DDB1 is predominantly a nuclear protein, and
SV5 V protein shows both cytoplasmic and nuclear lo-
calization (Paterson et al., 1995; Precious et al., 1995;
Watanabe et al., 1996). Although it may appear to be an
apparent dichotomy that a protein of the cytoplasmically
replicating SV5 should interact with a predominantly nu-
clear-localized cell protein, it should be noted that sev-
eral transcription factors are sequestered in the cyto-
plasm and are imported into the nucleus only when
required for function: the subcellular site of interaction of
SV5 V protein with DDB1 awaits to be determined. Be-
cause the DDB complex has been shown to interact with
E2F1 and to release E2F1 from Rb-mediated inhibition of
transcription (Hayes et al., 1998), it is possible that in
SV5-infected cells the V protein is complexed with DDB1,
which prevents DDB1 from interacting with E2F1 and
thus preventing cell cycle progression. An inhibition of
cell cycle progression may be important in pathogenesis
as rapidly dividing cells appear to present a poor envi-
ronment for viral replication. Fragmentation of the Golgi
apparatus in a mitotic cell causes an inhibition of vesicle
fusion, and hence glycoprotein transport is blocked (re-
viewed in Lowe et al., 1998). Such a block in glycoprotein
transport may be deleterious for the assembly of SV5, a
virus that shows a peak of virus release 18–24 h p.i., a
time scale similar to that of the cell cycle for many cell
types. Although Sendai virus V protein does not interact
with DDB1, it is also noted that the replication cycle of
Sendai virus is faster than that of SV5, mumps virus,
hPIV-2, or measles virus. Thus, it remains to be deter-
mined whether the paramyxoviruses affect cell cycle
progression and whether the V protein is involved in this
process through its interaction with DDB1.
MATERIALS AND METHODS
Plasmids
Plasmids pGEM2-P/V 203–1 (encoding the V protein) and
pGEM2-P/V 123 (encoding the P protein) were described
previously (Thomas et al., 1988). pGEM2-VD168–222 was
constructed by inserting a stop codon in the pGEM2-P/V
203–1 clone using an U.S.E. mutagenesis kit (Pharmacia
Biotech Inc., Piscataway, New Jersey). Fusion proteins of
V and P with Schistosoma japonicum GST (Frangioni and
Ne´el, 1993) were constructed to yield plasmids pGEM-
3X-V, GEX-3X-V, and pGEX-3X-P as described previously
(Lin et al., 1997). A portion of the pGEM2-VD168–222
containing the stop codon mutation was subcloned into
pGEX-3X-V to construct pGEX-3X-VD168–222. The cys-
teine codon-to-alanine codon mutations in the pGEM-V
cDNA were made using an U.S.E. mutagenesis kit (Phar-
macia), and restriction fragments containing the muta-
tions were subcloned into the pGEX-3X-V plasmid to
construct the pGEX-3X-V cysteine-to-alanine substitu-
tions. The plasmid pGEX-3X-H2 was constructed to en-
code a GST-fusion protein with the heptad repeat B
region of the SV5 fusion protein (F) (S. J. Bagai, R. E.
Dutch, and R. A. Lamb, unpublished observations). The
plasmid pGEX-4T-1-CM1 was constructed to encode a
GST-fusion protein with the influenza C virus matrix
(CM1) protein (A. Pekosz and R. A. Lamb, unpublished
observations). Oligonucleotides were synthesized by the
Northwestern University Biotechnology Facility.
The cDNA of the human 127-kDa subunit of DDB
(DDB1) was made by RT-PCR using primers specific for
the cDNA sequence (GenBank accession number
U32986), and the complete cDNA was cloned into pBlue-
script SK2 (Stratagene, La Jolla, California), and sub-
cloned into both pGEM3 (Promega, Madison, Wisconsin)
and pGEX-5X-3 (Pharmacia). The pGEX-2T-V plasmid en-
coding the GST-V fusion protein of the Edmonston strain
of measles virus was a kind gift of Dr. Peter Liston (Liston
and Briedis, 1994). The V open reading frame was am-
plified by PCR and subcloned into pGEM2. The pGEM3-V
plasmid encoding the V protein of the Greer strain of
hPIV2 was a gift of Dr. Griffith Parks. The pGEM-3zf(1)
MP1/2/9–3-4, which encodes the V protein of the RW
strain of the mumps virus, was described previously
(Paterson and Lamb, 1990). The pGEM3-SV V/C #4 plas-
mid, which encodes the V protein of the Z strain of
Sendai virus, was a kind gift of Dr. Sue Moyer. The V
open reading frame of the hPIV2 and mumps V cDNAs
were amplified by PCR using oligonucleotides containing
59-EcoRI and 39-XhoI restriction sites, and the Sendai
virus V open reading frame was amplified by PCR with
oligonucleotides containing 59BamHI and 39-XhoI restric-
tion sites. The PCR fragments were subcloned into
pGEX-5X-3 in frame to generate GST-V fusion proteins.
Cells and metabolic labeling
Monolayer cultures of a variant of the MDBK line of
bovine kidney cells, a variant of the MDCK line of canine
kidney cells, and CV-1 cells were grown as described
previously (Paterson et al., 1995). Monolayer cultures
(50–60% confluent) of uninfected or virus-infected MDCK
or CV-1 cells were labeled in 50% Dulbecco’s modified
Eagle’s medium (GIBCO BRL, Gaithersburg, MD), 50%
methionine- and cysteine-deficient Dulbecco’s modified
Eagle’s medium (GIBCO BRL), and 2% fetal calf serum
with 80 mCi (40 mCi/ml) [35S]Promix (Amersham Corp.,
Arlington Heights, Illinois) for 18–24 h. Cells were lysed
in 10 mM Tris–HCl, pH 7.2, 5 mM EDTA, 0.5% Nonidet
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P-40, 0.1% SDS, and 0.65 M NaCl. Lysates were clarified
by centrifugation at 55,000 rpm in a TLA 100.2 rotor
(Beckman Instruments, Inc., Palo Alto, California).
Virus growth and infections
The W3A strain of SV5 was grown in MDBK cells as
described previously (Peluso et al., 1977). For biochem-
ical experiments, subconfluent monolayers of CV-1 cells
were used and infected as described previously (Pater-
son et al., 1984). SV40 recombinant virus that expressed
the SV5 V protein under the control of the SV40 late
region promoter and containing the SV40 polyadenyla-
tion sequence was constructed and propagated as de-
scribed previously (Lamb and Lai, 1982). Subconfluent
monolayers of CV-1 cells were infected with the recom-
binant SV40-V stocks, and after 2 h at 37°C, the inoculum
was removed and replaced with labeling media (see
above) for 48 h at 37°C.
cDNAs encoding SV5 V, P and mutant V proteins;
measles virus V; and DDB1 protein were expressed us-
ing the recombinant vaccinia virus T7 RNA polymerase
transient expression system (Fuerst et al., 1986). Subcon-
fluent monolayers of CV-1 cells were infected with re-
combinant vaccinia virus vTF7–3 (m.o.i. ; 10 pfu/cell)
and incubated at 37°C for 30 min. The virus inoculum
was then removed, and cells were transfected with the
appropriate cDNA (pGEM2-P/V203–1, pGEM2-P/V123,
pGEM2-VD168–222, pGEM2 V measles, and pGEM3-
DDB1) using cationic liposomes prepared as described
previously (Rose et al., 1991). The 60-mm dishes were
transfected with 5.0 mg of the pGEM3-DDB1 plasmid and
2.5 mg of the pGEM2-V, P, or VD168–222 plasmids. Addi-
tional pGEM3 was added if necessary to ensure that 7.5
mg of DNA was present in each transfection. At 4.5–5 h
post-transfection, the transfection mixture was removed
and replaced with labeling media as described above for
18 h at 30°C. Cells were lysed and clarified as described
above except for experiments in which the measles V
protein and DDB1 were coimmunoprecipitated, where
cells were lysed in a buffer containing 10 mM Tris–HCl,
pH 7.2, 5 mM EDTA, 0.5% Nonidet P-40, and 0.15 M NaCl.
GST-fusion protein expression
Logarithmic growth phase cultures of DH1 Escherichia
coli cells carrying the pGEX constructs described above
were induced with 0.1 mM IPTG (Sigma Chemical Co., St.
Louis, Missouri), and the GST-fusion proteins were har-
vested as described previously (Lin et al., 1997). The
GST-fusion proteins were purified over glutathione–
Sepharose 4B beads (Pharmacia) according to the man-
ufacturer’s instructions. The fusion proteins were washed
extensively with phosphate-buffered saline deficient in
calcium and magnesium. To elute the fusion proteins, the
beads were boiled in protein lysis buffer (2% SDS, 62.5
mM Tris–HCl, pH 6.8, 5% dithiothreitol, 10% glycerol),
analyzed by SDS–PAGE on a 15% gel, and stained with
Coomassie brilliant blue.
GST-fusion protein selection of interacting proteins
Clarified cell lysates were incubated with 3 mg of GST
fusion proteins immobilized on glutathione–Sepharose
4B beads for 4–16 h at 4°C. The beads were then
washed five times with the lysis buffer and one time with
wash solution II (50 mM Tris–HCl, pH 7.4, 2.5 mM EDTA,
150 mM NaCl). The interacting proteins were removed
from the beads by boiling in protein lysis buffer and
analyzed by SDS–PAGE.
Coimmunoprecipitations
Cells infected with SV5, with recombinant SV40 ex-
pressing the SV5 V protein, or vTF7–3 and transfected
with the pGEM V or P plasmids were lysed and clarified
as described above. The clarified lysates were immuno-
precipitated with the following antisera: mAb P-k, a P-
and V-specific mAb (Randall et al., 1987); polyclonal an-
tisera to the measles V protein raised to a carboxyl-
terminal peptide containing residues 280–299 (measles
V) (Wardrop and Briedis, 1991) and kindly provided by Dr.
Peter Liston; or a rabbit polyclonal antiserum (XAP-1
peptide 2) that was made to a carboxyl-terminal peptide
containing residues 1113–1126 of the 127-kDa subunit of
DDB1 (Lee et al., 1995) and kindly provided by Dr. Betty
Slagle. Immunoprecipitation was performed as de-
scribed previously (Lamb et al., 1978) except the protein
A–Sepharose beads were washed five times with the cell
lysis buffer and one time with wash solution II. The
immunoprecipitated proteins were analyzed by SDS–
PAGE on a 15% gel, and the polypeptides were detected
by autoradiography.
Protein sequencing
GST-V selection of interacting proteins was performed
as described above with unlabeled MDCK cell lysates
from eight 10-cm-diameter dishes and polypeptides an-
alyzed by SDS–PAGE. The gel was reverse stained with
zinc sulfate and imidazole as described previously (Ortiz
et al., 1992). The ;115-kDa band was excised from the
gel and digested in situ with LysC protease. The pep-
tides were analyzed by mass spectrometry as described
previously (reviewed in Patterson and Aebersold, 1995;
Patterson et al., 1996), and the sequence of one of the
peptides was determined by mass spectrometry as de-
scribed previously (Patterson et al., 1996). The experi-
mental peptide sizes were compared with virtual LysC
digests of proteins contained in the Swiss Prot database.
Immunoblotting
GST-V selection of interacting proteins was performed
as described above, and the proteins associated with the
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GST fusion proteins were separated by SDS–PAGE and
transferred to Immobilon-P by semidry transfer using a
Transblot SD apparatus (BioRad, Hercules, California).
Immunoblotting was performed essentially as described
previously (Burnette, 1981; Paterson and Lamb, 1993). The
primary antibodies used included the following: a rabbit
polyclonal antiserum (DDB) that was raised to a carboxyl-
terminal peptide containing residues 776–1140 of the 127-
kDa subunit of DDB1 (Takao et al., 1993) and kindly pro-
vided by Dr. Vesna Rapic Otrin; a rabbit polyclonal anti-
serum (XAP-1 peptide 1) that was raised to an amino-
terminal peptide containing residues 198–213 (Lee et al.,
1995) and kindly provided by Dr. Betty Slagle; a rabbit
polyclonal antiserum (XAP-1 peptide 2) that was raised to a
carboxyl-terminal peptide containing residues 1113–1126
(Lee et al., 1995) and kindly provided by Dr. Betty Slagle; and
the SV5 V/P protein-specific mAb P-k. The secondary anti-
bodies used were peroxidase-conjugated goat antibodies
specific for either rabbit or mouse IgG (Cappel, Organon
Teknika, Durham, North Carolina). The immobilized pro-
teins were detected by light enhanced chemiluminescence
(Pierce Chemical Co., Rockford, Illinois).
In vitro transcription and translation of DDB1 and
GST-fusion protein selection of interacting proteins
with in vitro translated DDB1
pGEM3-DDB1 was used for in vitro mRNA transcrip-
tion using bacteriophage T7 RNA polymerase and the T7
mMessage mMachine kit according to the manufactur-
er’s instructions (Ambion Inc., Austin Texas). The DDB1
mRNA was translated in lysates of rabbit reticulocytes
according to the manufacturer’s instructions (Promega)
in the presence of 100 mCi [35S]methionine (Amersham).
The GST fusion proteins were incubated with 4 ml of the
in vitro translation mix in 1 ml Nonidet P-40 buffer [0.8%
Nonidet P-40 (Sigma), 20 mM Tris–HCl, 150 mM NaCl] at
4°C for 4 h. The GST fusion proteins were washed five
times with Nonidet P-40 buffer and one time with wash
solution II. The interacting proteins were analyzed by
SDS–PAGE on a 10% gel, and polypeptides were de-
tected by autoradiography.
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